[SS4] Relationship between COVID-19 and bacterial infection
Since last January we have been still in the middle of pandemic of COVID-19. Even though the pathogen causing COVID-19 is the Corona virus, it is required to pay attention to influence of this viral disease on bacteriology and bacterial infectious disease from various aspects. Thinking of the significance of secondary pulmonary bacterial infection in influenza, it is reasonable to careful to bacterial infection under COVID-19. In this point accumulated data on COVID-19 since last January revealed the coincidence of bacterial pneumonia is not so frequent as is the case with influenza. These findings suggest proper attitude towards empiric antibiotic treatment has to be noted from the point of antimicrobial stewardship It is important to stress on the importance of appropriate sampling of respiratory specimens including 2 sets of blood culture before initiation of antibiotics. It is important to further elucidate the epidemiology of concomitant as well as secondary bacterial infections complicated with COVID-19. Another important aspect of the COVID-19 is its impact on epidemiology of bacterial diseases. It is demonstrated that the number of reported tuberculosis is obviously decreased by COVID-19 pandemic, suggesting the delay of diagnosis and resultant future upsurge of advanced tuberculosis associated with their close contact. As for mycobacteriology BCG has been suggested to be possibly protective against the COVID-19. While precise mechanism remains to be known, it is interesting to discuss the intensification and training of innate immunity by BCG
this einfectious disease reached over 0.38 million and 5600 people in Japan, and the state of emergency was declared. The COVID-19 takes away everyday life and forces us to change medical, political, economical, educational, cultural and social actions. The COVID-19 is an acute respiratory infection caused by a new species of Corona virus much unelucidated. As this disease changes human immune system and microbiome, it affects some bacterial, mycobacterial or fungal infections, and may trigger nosocomial infections or spreads antimicrobial resistance. The Japanese Society for Bacteriology of which mission is basic research, epidemiological analysis, and education, has to respond these serious problems. In this symposium, we will discuss the strategy, future prospect for COVID-19 and the associated bacterial phenomenon.
this einfectious disease reached over 0.38 million and 5600 people in Japan, and the state of emergency was declared. The COVID-19 takes away everyday life and forces us to change medical, political, economical, educational, cultural and social actions. The COVID-19 is an acute respiratory infection caused by a new species of Corona virus much unelucidated. As this disease changes human immune system and microbiome, it affects some bacterial, mycobacterial or fungal infections, and may trigger nosocomial infections or spreads antimicrobial resistance. The Japanese Society for Bacteriology of which mission is basic research, epidemiological analysis, and education, has to respond these serious problems. In this symposium, we will discuss the strategy, future prospect for COVID-19 and the associated bacterial phenomenon.